Search
for
Sort by
Research 61–90 of 1000+
- Docetaxel-induced Psoriasis
- Chemically Induced Hair Loss/Alopecia
- Poster Abstracts
- Sodium Valproate-Induced Hyperpigmentation
- Cutaneous manifestations associated with substance use disorders
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Non-hemorrhage-related adverse effects of rivaroxaban
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Dermatological Drugs, Topical Agents, and Cosmetics
- Clin-Alert
- Multiple minute digitate hyperkeratosis
- TOXIC EPIDERMAL NECROLYSIS
- Dermatolojik Problemler ve COVID-19
- Incidence of skin diseases diagnosed in a public institution: comparison between 2003 and 2014
- Severe cutaneous adverse reactions to drugs
- Cutaneous thrombosis and ANCA-positive vasculitis associated with propylthiouracil therapy
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Editorial: Prevention and treatment of skin diseases
- Reporting on Adverse Clinical Events
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Parkinson's disease and skin
- Oral cyclosporin does not arrest progression of androgenetic alopecia
- Alopecia Areata
- Aldesleukin
- NEFAZODONE
- “Degeneration” in Dermatopathology
- Azole Antifungal–Induced Erythema Annulare Centrifugum in a Case of Extensive Tinea
- Analysis of Prescribing Practices in the Dermatology Outpatient Department of a Tertiary Care Teaching Hospital